Literature DB >> 22389204

MHC class II tetramers.

Gerald T Nepom1.   

Abstract

MHC class II tetramers have emerged as an important tool for characterization of the specificity and phenotype of CD4 T cell immune responses, useful in a large variety of disease and vaccine studies. Issues of specific T cell frequency, biodistribution, and avidity, coupled with the large genetic diversity of potential class II restriction elements, require targeted experimental design. Translational opportunities for immune disease monitoring are driving the rapid development of HLA class II tetramer use in clinical applications, together with innovations in tetramer production and epitope discovery.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22389204      PMCID: PMC3297979          DOI: 10.4049/jimmunol.1102398

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  69 in total

1.  MHC class II tetramers identify peptide-specific human CD4(+) T cells proliferating in response to influenza A antigen.

Authors:  E J Novak; A W Liu; G T Nepom; W W Kwok
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

2.  The relationship of MHC-peptide binding and T cell activation probed using chemically defined MHC class II oligomers.

Authors:  J R Cochran; T O Cameron; L J Stern
Journal:  Immunity       Date:  2000-03       Impact factor: 31.745

3.  Specificity and detection of insulin-reactive CD4+ T cells in type 1 diabetes in the nonobese diabetic (NOD) mouse.

Authors:  Frances Crawford; Brian Stadinski; Niyun Jin; Aaron Michels; Maki Nakayama; Philip Pratt; Philippa Marrack; George Eisenbarth; John W Kappler
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-26       Impact factor: 11.205

4.  Identification and functional characterization of T cells reactive to citrullinated vimentin in HLA-DRB1*0401-positive humanized mice and rheumatoid arthritis patients.

Authors:  Omri Snir; Mary Rieck; John A Gebe; Betty B Yue; Crystal A Rawlings; Gerald Nepom; Vivianne Malmström; Jane H Buckner
Journal:  Arthritis Rheum       Date:  2011-10

5.  Uveitis-associated epitopes of retinal antigens are pathogenic in the humanized mouse model of uveitis and identify autoaggressive T cells.

Authors:  Mary J Mattapallil; Phyllis B Silver; Joseph J Mattapallil; Reiko Horai; Zaruhi Karabekian; J Hugh McDowell; Chi-Chao Chan; Eddie A James; William W Kwok; H Nida Sen; Robert B Nussenblatt; Chella S David; Rachel R Caspi
Journal:  J Immunol       Date:  2011-07-15       Impact factor: 5.422

6.  Increased frequencies of myelin oligodendrocyte glycoprotein/MHC class II-binding CD4 cells in patients with multiple sclerosis.

Authors:  Khadir Raddassi; Sally C Kent; Junbao Yang; Kasia Bourcier; Elizabeth M Bradshaw; Vicki Seyfert-Margolis; Gerald T Nepom; William W Kwok; David A Hafler
Journal:  J Immunol       Date:  2011-06-08       Impact factor: 5.422

7.  Ara h 1-reactive T cells in individuals with peanut allergy.

Authors:  Jonathan H DeLong; Kelly Hetherington Simpson; Erik Wambre; Eddie A James; David Robinson; William W Kwok
Journal:  J Allergy Clin Immunol       Date:  2011-04-02       Impact factor: 10.793

8.  Papillomavirus-specific CD4+ T cells exhibit reduced STAT-5 signaling and altered cytokine profiles in patients with recurrent respiratory papillomatosis.

Authors:  Eddie A James; James A DeVoti; David W Rosenthal; Lynda J Hatam; Bettie M Steinberg; Allan L Abramson; William W Kwok; Vincent R Bonagura
Journal:  J Immunol       Date:  2011-04-29       Impact factor: 5.422

9.  Direct enumeration of Borrelia-reactive CD4 T cells ex vivo by using MHC class II tetramers.

Authors:  A L Meyer; C Trollmo; F Crawford; P Marrack; A C Steere; B T Huber; J Kappler; D A Hafler
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

10.  Differentiation stage determines pathologic and protective allergen-specific CD4+ T-cell outcomes during specific immunotherapy.

Authors:  Erik Wambre; Jonathan H DeLong; Eddie A James; Rebecca E LaFond; David Robinson; William W Kwok
Journal:  J Allergy Clin Immunol       Date:  2011-10-05       Impact factor: 10.793

View more
  62 in total

1.  Functional heterogeneity in the CD4+ T cell response to murine γ-herpesvirus 68.

Authors:  Zhuting Hu; Marcia A Blackman; Kenneth M Kaye; Edward J Usherwood
Journal:  J Immunol       Date:  2015-02-06       Impact factor: 5.422

2.  Memory T cells specific to citrullinated α-enolase are enriched in the rheumatic joint.

Authors:  Jennifer Pieper; Anatoly Dubnovitsky; Christina Gerstner; Eddie A James; Mary Rieck; Genadiy Kozhukh; Karolina Tandre; Sara Pellegrino; John A Gebe; Lars Rönnblom; Tatyana Sandalova; William W Kwok; Lars Klareskog; Jane H Buckner; Adnane Achour; Vivianne Malmström
Journal:  J Autoimmun       Date:  2018-05-28       Impact factor: 7.094

3.  Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion.

Authors:  Thomas Delong; Timothy A Wiles; Rocky L Baker; Brenda Bradley; Gene Barbour; Richard Reisdorph; Michael Armstrong; Roger L Powell; Nichole Reisdorph; Nitesh Kumar; Colleen M Elso; Megan DeNicola; Rita Bottino; Alvin C Powers; David M Harlan; Sally C Kent; Stuart I Mannering; Kathryn Haskins
Journal:  Science       Date:  2016-02-12       Impact factor: 47.728

4.  Progression of relapsing-remitting demyelinating disease does not require increased TCR affinity or epitope spread.

Authors:  Anna E Kersh; Lindsay J Edwards; Brian D Evavold
Journal:  J Immunol       Date:  2014-09-29       Impact factor: 5.422

Review 5.  T-cell biology in immunotherapy.

Authors:  John W Steinke; Monica G Lawrence
Journal:  Ann Allergy Asthma Immunol       Date:  2014-01-14       Impact factor: 6.347

6.  A population response analysis approach to assign class II HLA-epitope restrictions.

Authors:  Sinu Paul; Myles B C Dillon; Cecilia S Lindestam Arlehamn; Huang Huang; Mark M Davis; Denise M McKinney; Thomas Jens Scriba; John Sidney; Bjoern Peters; Alessandro Sette
Journal:  J Immunol       Date:  2015-05-06       Impact factor: 5.422

7.  Mass spectrometry-based identification of MHC-bound peptides for immunopeptidomics.

Authors:  Anthony W Purcell; Sri H Ramarathinam; Nicola Ternette
Journal:  Nat Protoc       Date:  2019-05-15       Impact factor: 13.491

Review 8.  Vaccination against atherosclerosis.

Authors:  Kouji Kobiyama; Ryosuke Saigusa; Klaus Ley
Journal:  Curr Opin Immunol       Date:  2019-03-29       Impact factor: 7.486

9.  Age-dependent divergent effects of OX40L treatment on the development of diabetes in NOD mice.

Authors:  Christine S Haddad; Palash Bhattacharya; Khaled Alharshawi; Alejandra Marinelarena; Prabhakaran Kumar; Osama El-Sayed; Hatem A Elshabrawy; Alan L Epstein; Bellur S Prabhakar
Journal:  Autoimmunity       Date:  2016-05-31       Impact factor: 2.815

10.  Cutting edge: CD4 T cells reactive to an islet amyloid polypeptide peptide accumulate in the pancreas and contribute to disease pathogenesis in nonobese diabetic mice.

Authors:  Rocky L Baker; Thomas Delong; Gene Barbour; Brenda Bradley; Maki Nakayama; Kathryn Haskins
Journal:  J Immunol       Date:  2013-09-16       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.